EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

RANTES expression in psoriatic skin, and regulation of RANTES and IL-8 production in cultured epidermal keratinocytes by active vitamin D3 (tacalcitol)



RANTES expression in psoriatic skin, and regulation of RANTES and IL-8 production in cultured epidermal keratinocytes by active vitamin D3 (tacalcitol)



British Journal of Dermatology 138(1): 63-70



The chemokine RANTES is a chemoattractant for eosinophils, T lymphocytes of memory phenotype and monocytes, suggesting that it plays an important part in chronic inflammatory and allergic diseases. In various types of cells, RANTES production is markedly induced by tumour necrosis factor (TNF)-alpha and interferon (IFN)-gamma in combination. Psoriasis vulgaris is a chronic cutaneous inflammatory disease. Cytokines and chemokines produced by T cells and epidermal keratinocytes, such as interleukin (IL) 8, are involved in the pathogenesis of psoriasis. T-cell clones obtained from psoriatic skin have been shown to produce the Th1 cytokine IFN-gamma. In addition, abnormal expression of proinflammatory cytokines including TNF-alpha has been observed in psoriatic lesions. These reports led us to hypothesis that psoriatic skin could provide epidermal keratinocytes with TNF-alpha and IFN-gamma, so that keratinocytes could produce RANTES. In this study, we addressed the question as to whether RANTES was involved in psoriasis vulgaris. Immunohistochemistry of skin biopsies showed RANTES was present in the intercellular spaces between epidermal keratinocytes, in the fully developed lesions from the middle to the edge of psoriatic plaques, but not in the perilesional uninvolved and healthy control skin. Further, we confirmed the production of RANTES, together with IL-8, by cultured normal human epidermal keratinocytes, using an enzyme-linked immunosorbent assay. Stimulation with TNF-alpha and IFN-gamma in combination synergistically increased the RANTES production in this system. These results clearly demonstrate the expression of RANTES in psoriatic lesions and suggest the involvement of this chemokine in the outcome of cutaneous inflammatory diseases. Tacalcitol (1 alpha,24(R)-dihydroxyvitamin D3), an active vitamin D3 analogue, inhibited RANTES and IL-8 production in cultured normal epidermal keratinocytes. This result indicates that active vitamin D3 is effective in the regulation of chemokine production by epidermal keratinocytes, which may partly account for its action as an antipsoriatic drug.

(PDF emailed within 0-6 h: $19.90)

Accession: 009289794

Download citation: RISBibTeXText

PMID: 9536224

DOI: 10.1046/j.1365-2133.1998.02027.x



Related references

Tacalcitol, an active vitamin D3, induces nerve growth factor production in human epidermal keratinocytes. Skin Pharmacology and Applied Skin Physiology 14(4): 226-233, 2001

The expression of CC chemokine receptor 3 is detectable in normal human skin and is enhanced in inflammatory skin diseases RANTES, but not eotaxin, IL-4 or interferon-01gamma, up-regulates CCR-3 expression on cultured human keratinocytes. Journal of Investigative Dermatology 112(4): 600, April, 1999

Demonstration and functional analysis of IL-10 receptors in human epidermal cells: decreased expression in psoriatic skin, down-modulation by IL-8, and up-regulation by an antipsoriatic glucocorticosteroid in normal cultured keratinocytes. Journal of Immunology 159(12): 6291-6297, 1998

Demonstration and functional analysis of IL-10 receptors in human epidermal cells: decreased expression in psoriatic skin, down-modulation by IL-8, and up-regulation by an antipsoriatic glucocorticosteroid in normal cultured keratinocytes. Journal of Immunology 159: 91-7, 1997

Expression of RANTES in the lung tissue of asthmatic rats, and the intervention effect of vitamin D on RANTES expression. Zhongguo Dang Dai Er Ke Za Zhi 14(11): 863-868, 2013

Rosiglitazone inhibits RANTES expression by human epidermal keratinocytes. European Journal of Dermatology 19(2): 176-177, 2009

Vasoactive intestinal peptide enhances IL-6, IL-8, RANTES production from transformed epidermal keratinocytes DJM-1. Journal of Dermatological Science 23(3): 204, August, 2000

Expression of the cytokine RANTES in human rheumatoid synovial fibroblasts. Differential regulation of RANTES and interleukin-8 genes by inflammatory cytokines. Journal of Biological Chemistry 268(8): 5834-5839, 1993

Enhanced production of RANTES, an eosinophil chemoattractant factor, by cytokine-stimulated epidermal keratinocytes. International Archives of Allergy and Immunology 114 Suppl 1: 28-32, 1997

Eotaxin, MCP-4, MCP-3, RANTES and GMCSF gene expression in skin fibroblasts and keratinocytes Implications for eosinophil skin infiltration. Journal of Dermatological Science 16(SUPPL 1): S181, March, 1998

Wy14643, an agonist for PPARĪ±, down-regulates expression of TARC and RANTES in cultured human keratinocytes. Experimental Dermatology: -, 2016

Upregulation of RANTES in psoriatic keratinocytes: A possible pathogenic mechanism for psoriasis. Acta Dermato-Venereologica 79(1): 9-11, 1999

Reduction of RANTES expression in lesional psoriatic skin after narrow band ultraviolet therapy: a possible marker of therapeutic efficacy. European Journal of Dermatology 22(4): 481-487, 2013